and elbows is normal. Power at the hips, knees, and wrists is grade 3 and at the ankles remains zero. Tendon reflexes have returned in the arms and knees and sensation has returned fully. Fine hand function remains impaired and the patient can walk a few steps with support.
Discussion
Guillain-Barre syndrome is often thought to have a benign prognosis, but 7% of patients die and a further 16% suffer residual disability''. Early diagnosis and management may shorten the course and reduce morbidity'. Plasma exchange within 7 days of onset of neurological symptoms reduces ventilation time and hastens clinical improvement'.
Features of patients with poor outcome include severe deficit requiring ventilation and failure to improve within 3 weeks of reaching peak deficit", Quadriplegia appearing over 2-5 days is associated with the most severe residual deficit leading to permanent chairbound status", However, an unduly pessimistic attitude towards recovery for the severely disabled at 6 months does not seem justified, since improvement may only plateau at 18-24 months", In the elderly, prospects for recovery are quite good", This woman's illness had an unusually fulminant onset, with a poor prognosis suggested by previous criteriav'. Vigorous
Meeting reports

Spongiform encephalopathies: implications of recent developments
Keywords: spongiform encephalopathies; man; animals
The spongiform encephalopathies are a group of diseases of man and animals which include CreutzfeldtJakob disease (CJD), Kuru, Gerstmann-StrausslerScheinker disease, scrapie and transmissible mink encephalopathy. The most striking recent development in this field has been the emergence of a new disease; bovine spongiform encephalopathy (BSE). This new disease has captured the imagination of the press under headlines such as 'Mad Cow Disease' and 'Madness and Death in the Dairy Cow', and the possible implications of the condition for human and animal health have received wide attention. It was therefore no surprise that at the recent joint meeting of the sections of Comparative Medicine, Pathology, and Epidemiology & Community Health entitled 'Spongiform encephalopathies: implications of recent developments', BSE was the subject of five of the nine speakers.
Dr T Crowe (Northwick Park Hospital) began the meeting by discussing the spongiforrn encephalopathies of man, with particular reference to Gerstmann-Straussler-Scheinker disease (GSS). GSS is a rare disease which, unlike the sporadic spongiform encephalopathies of man, is transmitted as autosomal dominant familial cerebellar ataxia and dementia. Fifteen per cent of Creutzfeldt-Jakob disease cases also appear to be familial, but the GSS cases can be distinguished by their slower onset, the presence of cerebellar ataxia and by more prominent accumulation of amyloid in the brain. It has been treatment in this case has been worthwhile and at 6 months from onset active rehabilitation is continuing.
Diagnosis of GBS in the elderly may be overlooked because of its varied presentation and the possible coexistence of neurological disease. This illustration of how a very fulminant onset of disease may present with features suggestive of acute spinal cord compression shows that GBS can be an important, remedial cause of neurological disease in this age group, and how a positive attitude to treatment is justified.
known for some time that the protein found in the amyloid plaques is essential for transmission of spongiform encephalopathies and that it is coded for by the 'prion' gene. Detailed studies on a number of families with GSS and familial CJD, have identified several mutations in this gene. In three of the four mutations described the abnormal mutation was not seen in any unaffected individual, suggesting that it might be directly pathogenic. However, in the fourth example an alteration at codon 129 identified in a number of GSS families was also found in cases of familial CJD, sporadic CJD, iatrogenic (growth hormone therapy associated) CJD and in a proportion of normal individuals. This posed the intriguing question of whether there may be a susceptibility gene, similar to the SINC gene in mice, or indeed whether all the mutations so far described might in some way control susceptibility. Dr J Hope (Neuropathogenesis Unit, Edinburgh) then reviewed the nature of the pathogenic agent. The infectious agent has long been known to be resistant to formalin and autoclaving. It is relatively insensitive to ionising radiation, although it does show a high oxygen enhancement ratio. This was previously thought to indicate that the infective particle consisted of lipid and polysaccharide, but is now considered to be consistent with it being a protein with an oxygen sensitive moiety. The molecular structure of the scrapie agent is still unknown but evidence has been accumulating in support of the hypothesis that although scrapie is caused by an environmental agent, prion protein (PRP) is involved. A possible role for PRP could be to act as a receptor site where the agent might attach and this kind of theory is now being tested using transgenic techniques, Recent experiments involved inserting the hamster PRP gene into mice. The mice did not develop scrapie but when challenged showed a greatly reduced incubation period. Scrapie is a naturally occurring disease of sheep. Infection occurs at or around the time of lambing and the incubation period is at least 3-4 years. Dr H Fraser (Neuropathogenesis Unit, Edinburgh) emphasized that although scrapie is manifested as a disease of the nervous system, initial infection and replication occurs in the lymphoreticular system, where it produces no visible lesions and no apparent functional deficit. There is some evidence to suggest that infection then spreads via autonomic connections to the target neurons ofthe central nervous system.
Fifteen strains of scrapie have been identified and five have been cloned. Primary isolation of strains involves injection of brain from field cases into assay animals. More than one wild type strain is often isolated and subsequent passage results in the production of mutant strains, which differ in the pattern of pathology produced and in the length of the incubation period.
Bovine spongiform encephalopathy (BSE) is a new disease of cattle, which has been recognized in the United Kingdom and in Ireland. The pathology is similar to that seen in other spongiform encephalopathies and was described in detail by Dr G Wells (Central Veterinary Laboratory, Weybridge). The lesions include vacuolation of neuronal perikarya and neuropil, gliosis and the presence of scrapieassociated fibrils, but aggregation of fibril protein to form amyloid plaques has not so far been observed. Vacuolation is found throughout the brain, but its density varies according to the anatomical site and becomes more severe as the disease progresses. Since diagnostic laboratories have been dealing with up to 150 cases per week, it has not been possible to confirm cases by experimental transmission. Diagnosis has therefore depended on the clinical signs and on histological examination of brains from affected cattle.
Dr J W Wilesmith (Central Veterinary Laboratory, Weybridge) then described the methods used in the initial investigations into BSE. Results from computer simulation modelling suggested that exposure to a scrapie-like agent commenced in 1981/2, that the incubation period was 2.5-8 years, and that most affected animals had been exposed as calves. Epidemiological studies supported the role of feed in the epidemic and since rendered sheep carcasses are a constituent of meat and bone meal, factors which might have been responsible for the apparently sudden exposure of large numbers of animals to a scrapie-like agent via cattle feed were examined. The change away from the use of hydrocarbon solvent fat extraction, which occurred relatively suddenly throughout the rendering industry in 1981, seems to have been an important factor. The feeding of ruminant-derived products to ruminants has now been banned, but it remains to be seen how effective this will be in controlling the epidemic, which at present has an incidence of just over 500 cases per month. If it is totally effective there should be no new cases by the end of the 1990s even if in utero transmission does occur. However, if there were horizontal transmission, there will be an initial increase in cases in 1992/3 followed by a fall in incidence due to the long incubation period, and then an increase at an unknown rate.
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Dr M Preece (Institute of Child Health) spoke about the risk of using human pituitary-derived growth hormone. He described a number of patients in the United Kingdom, United States and New Zealand, who had developed atypical CJD following administration of human-derived growth hormone during childhood. The incidence of the illness was 1 : 1000 and differed from CJD in that cerebellar problems were a striking feature, the course was more rapid, and dementia occurred late in the disease. Although safer preparation techniques became available in the late 1970s and early 1980s, it was decided to withdraw human sourced growth hormone in May 1985 -a time which conveniently coincided with the introduction of recombinant hormone. The incidence of overt disease associated with growth hormone treatment remains at two out of 2000 patients treated in the UK. The remaining patients, some of whom may still be in a subclinical phase, might provide a source of infection in the community. They could become blood or organ donors and since they constitute a potentially fertile age group the possibility of transplacental infection would have to be considered.
Returning to BSE, Dr M L Woolfe (Ministry of Agriculture Food Science Division) discussed the implications of the disease for bovine-based and bovine-derived foods. Examination of food hazards involves 'risk analysis', and for most microbial agents toxins or chemical agents the identity, occurrence, infective dose, heat resistance and therefore appropriate treatment is known. As had been made clear by previous speakers, the identity of the infectious agent in the spongiform encephalopathies remained an enigma. The assessment of risk in BSE was therefore based on what is known about scrapie. Clinically affected cattle are removed from the food chain and organs known to carry a high risk of infection in scrapie, namely brain, spinal cord, spleen, thymus, tonsils and intestines are now also banned from human consumption. Material from calves of under 6 months of age is exempt from the ban on the grounds that, in naturally occurring scrapie, tissues are not infective in the first 10 months of the disease. Dr A Lee (Veterinary Medicines Directorate) restricted her paper to the implications of BSE on the production of veterinary medicines. A questionnaire sent to manufacturers revealed that about 10% of veterinary products contained bovine or ovine material. In the light of the nature ofthe disease the following guidelines were issued: material should be obtained from closed herds. which had not been fed on ruminant derived feed. Spleen should not be used and material should not be obtained from animals subjected to brain-penetrative stunning. A small and decreasing number of manufacturers did not yet fully comply with the guidelines, but Dr Lee concluded by reassuring the audience that those for whom BSE does have implications have changed their source of animal products, and that no problems have so far been identified.
Summing up Professor M A Epstein (University of Oxford)congratulated Dr Wilesmith on his epidemiological studies of BSE before going on to give an overview of the Southwood report. The role of the Southwood Committee had been to weigh up the risk factors and make various recommendations. On the basis of their findings it was recommended that the addition of components of ruminant origin to ruminant feed should be banned indefinitely; that infected carcasses and milk from suspected cases should be destroyed; that placentae of cattle should be handled in a way which minimized the likelihood of exposure; and that specialist groups should be informed of the possibility of the emergence of new forms of CJD. Their conclusions were appropriately summarized by Professor Epstein in the following quotation from the report; 'It is likely that cattle will prove to be a "deadend host" and most unlikely that BSE will have any implications for human health. Nevertheless, if our assessments of these likelihoods are incorrect the Health, sickness and water in the UK Keywords: water; environmental health; pollution An audience can make or mar an evening. Ninety. nine times out of a hundred the Open Section rises to the occasion, sometimes turning an otherwise average session into a good one with questions and discussion; sometimes shifting the experience from the good to the sparkling. Never have I known an audience actually to detract from a talk but there is a first time for everything and this threatened to be it. Anxiety was caused initially by finding, on each chair, a violent attack on fluoridation, placed there not by the speakers but by a visitor to the society.
This having been dealt with and cameras and tape recorders repelled, the scientific part of the meeting began. From the chair Professor Norman Noah gave an account of a festival held earlier this year in Hyde Park to celebrate British food and farming. The pigs on show became increasingly dehydrated because they refused to drink London tap water. Eventually, they were restored with the help of Harrod's own artesian well. Water, he pointed out, is no small matter: it covers two-thirds of the earth's surface and makes up three-quarters of the human body. He did not elaborate on the power of water to arouse emotions, a power that perhaps owes its origins to the importance it holds in everyday life. Sadly there were no Jungian analysts evident in the audience.
The first speaker was Dr Jenny Colbourne, Operational Science Manager for Thames Water. Her theme was the legal requirements on supplying authorities and, as became evident in question time, on all of us. There have been recent changes in British legislation about water quality. Stimulated by the EC they have found form in the Water Bill of July this year, which has given, for the first time, 8 mandatory definition of acceptability, applying to everyone supplying water. Both health and aesthetic factors are now included (the latter encompassing, for example, implications would be extremely serious.' This statement aptly underlined the fact that despite the advances which have been made, many questions regarding the pathogenesis of the spongiform encephalopathies of man and animals still remain to be answered. odour). Before this legislattion we had to get by with the stricture that water should be wholesome. By far the most important of the 64 parameters now determining what we mean by acceptable water are those related to its microbiological quality. There is a varying frequency of sampling but if pathogens are found the utility responsible for the supply must agree with the relevant health authority on appropriate steps to be taken.
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She then pointed to one of the many facts that were evidently not known by most people present: much deterioration in water quality comes after the supply has reached a building. Water tanks are rarely looked after properly and many contain any number of potentially lethal substances and objects, dead pigeons being named as an example. Water filters often do more harm than good and the warm conditions of many buildings lead to the dangerous amplification of harmful organisms.
Care is also needed in testing water. Monitoring by culture is the classical method but organisms may be dormant. Even the latest, most highly recommended technology is no guarantee of success as was demonstrated recently in Oxfordshire when one reservoir was contaminated, possibly from farm slurry, leading to a serious outbreak of disease.
Almost in passing Dr Colbourne touched on a point that surfaced later, one that could have filled a whole evening's discussion: there are many groups in the community who are vulnerable to the contents of ordinary water, the elderly being one example. Fifteen million Americans fall into this category.
The next speaker was Dr R Stanwell-Smith (Medical Officer for Environmental Health, Bristol and Weston Health Authority) who started with some amusing and illustrative historical references (Thames water was, in earlier times, referred to as a monster soup). A wheel has come full circle in Britain; at the turn of the 19th century many of the poor used public pumps while the rich drank bottled water. We contemplated our Perrier.
History is not so long ago. A major turning point in this country was the 1937 Croydon typhoid outbreak when many common mistakes were made, 
